Log In
BCIQ
Print this Print this
 

INT41

  Manage Alerts
Collapse Summary General Information
Company Vybion Inc.
DescriptionIntrabody drug delivered by gene therapy that blocks gene dysregulation
Molecular Target
Mechanism of ActionGene therapy
Therapeutic ModalityGene therapy
Latest Stage of DevelopmentPreclinical
Standard IndicationHuntington's disease (HD)
Indication DetailsTreat Huntington's disease (HD)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today